Advertisement

Companies value their intellectual property portfolios on the strength of their claims and their ability to translate patents into products that will make money over time. This paper provides general guidelines for deriving intellectual property valuations for medical device companies that are considering a merger or acquisition.

Click here to access the Nerac Inc. white paper.

Advertisement
Advertisement